Search research articles
Contact Us
Filters
Showing results (81-90 of 228) with videos related to
Page
of 23
Sort By:
Cancer Letters
|
March 28, 2008
Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement
Hirokazu Ogino, Seiji Yano, Soji Kakiuchi, et al.
Cancer Research
|
February 6, 2013
EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition
Takayuki Nakagawa, Shinji Takeuchi, Tadaaki Yamada, et al.
International Journal of Oncology
|
March 4, 2020
Histone deacetylase inhibitor OBP‑801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1‑dependent apoptosis
Yusuke Chihara, Yosuke Iizumi, Mano Horinaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 22, 2012
[A case of poorly-differentiated neuroendocrine carcinoma of the ascending colon with multiple liver metastases successfully treated with cisplatin and irinotecan]
Kaname Yamashita, Daisuke Ishikawa, Shigeki Nanjo, et al.
Respiratory Medicine
|
September 20, 2006
A novel potent inhibitor of inducible nitric oxide synthase, ONO-1714, reduces hyperoxic lung injury in mice
Tatsuya Yuba, Kazuhiro Nagata, Tadaaki Yamada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2009
Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors
Wei Wang, Qi Li, Tadaaki Yamada, et al.
Respiratory Medicine Case Reports
|
October 13, 2018
Successful sequential treatment of refractory tumors caused by small cell carcinoma transformation and EGFR-T790M mutation diagnosed by repeated genetic testing in a patient with lung adenocarcinoma harboring epidermal growth factor receptor mutations: A case report
Naoya Nishioka, Tadaaki Yamada, Sachi Harita, et al.
Journal of Thoracic Disease
|
November 16, 2023
Etoposide soft capsule combined with anlotinib in the third-line treatment of advanced non-small cell lung cancer: a retrospective cohort study
Yi-Jun Dai, Yan-Ru Qiu, Jian-Guang Lin, et al.
Cancers
|
September 14, 2024
The Significance of Longitudinal Psoas Muscle Loss in Predicting the Maintenance Efficacy of Durvalumab Treatment Following Concurrent Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer: A Retrospective Study
Haruka Kuno, Naoya Nishioka, Tadaaki Yamada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2011
The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer
Kazuo Yasumoto, Tadaaki Yamada, Atsuhiro Kawashima, et al.
Page
of 23
Search research articles
Search
Showing results (81-90 of 228) with videos related to
Sort By:
Page
of 23
Cancer Letters
|
March 28, 2008
Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement
Hirokazu Ogino, Seiji Yano, Soji Kakiuchi, et al.
Cancer Research
|
February 6, 2013
EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition
Takayuki Nakagawa, Shinji Takeuchi, Tadaaki Yamada, et al.
International Journal of Oncology
|
March 4, 2020
Histone deacetylase inhibitor OBP‑801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1‑dependent apoptosis
Yusuke Chihara, Yosuke Iizumi, Mano Horinaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 22, 2012
[A case of poorly-differentiated neuroendocrine carcinoma of the ascending colon with multiple liver metastases successfully treated with cisplatin and irinotecan]
Kaname Yamashita, Daisuke Ishikawa, Shigeki Nanjo, et al.
Respiratory Medicine
|
September 20, 2006
A novel potent inhibitor of inducible nitric oxide synthase, ONO-1714, reduces hyperoxic lung injury in mice
Tatsuya Yuba, Kazuhiro Nagata, Tadaaki Yamada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2009
Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors
Wei Wang, Qi Li, Tadaaki Yamada, et al.
Respiratory Medicine Case Reports
|
October 13, 2018
Successful sequential treatment of refractory tumors caused by small cell carcinoma transformation and EGFR-T790M mutation diagnosed by repeated genetic testing in a patient with lung adenocarcinoma harboring epidermal growth factor receptor mutations: A case report
Naoya Nishioka, Tadaaki Yamada, Sachi Harita, et al.
Journal of Thoracic Disease
|
November 16, 2023
Etoposide soft capsule combined with anlotinib in the third-line treatment of advanced non-small cell lung cancer: a retrospective cohort study
Yi-Jun Dai, Yan-Ru Qiu, Jian-Guang Lin, et al.
Cancers
|
September 14, 2024
The Significance of Longitudinal Psoas Muscle Loss in Predicting the Maintenance Efficacy of Durvalumab Treatment Following Concurrent Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer: A Retrospective Study
Haruka Kuno, Naoya Nishioka, Tadaaki Yamada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2011
The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer
Kazuo Yasumoto, Tadaaki Yamada, Atsuhiro Kawashima, et al.
Page
of 23